Exner M - Search Results

1

p-Hydroxyphenylacetaldehyde, the major product of tyrosine oxidation by the activated myeloperoxidase system can act as an antioxidant in LDL.

Exner M, Alt E, Hermann M, Hofbauer R, Kapiotis S, Quehenberger P, Speiser W, Minar E, Gmeiner B. Exner M, et al. FEBS Lett. 2001 Feb 9;490(1-2):28-31. doi: 10.1016/s0014-5793(01)02131-7. FEBS Lett. 2001. PMID: 11172805 Free article.

2

Thiocyanate catalyzes myeloperoxidase-initiated lipid oxidation in LDL.

Exner M, Hermann M, Hofbauer R, Hartmann B, Kapiotis S, Gmeiner B. Exner M, et al. Free Radic Biol Med. 2004 Jul 15;37(2):146-55. doi: 10.1016/j.freeradbiomed.2004.04.039. Free Radic Biol Med. 2004. PMID: 15203186

3

Copper- and magnesium protoporphyrin complexes inhibit oxidative modification of LDL induced by hemin, transition metal ions and tyrosyl radicals.

Kapiotis S, Hermann M, Exner M, Laggner H, Gmeiner BM. Kapiotis S, et al. Among authors: exner m. Free Radic Res. 2005 Nov;39(11):1193-202. doi: 10.1080/10715760500138981. Free Radic Res. 2005. PMID: 16298745

4

Products of the reaction of HOCl with tryptophan protect LDL from atherogenic modification.

Kapiotis S, Jirovetz L, Hermann M, Laggner H, Exner M, Esterbauer H, Gmeiner BM. Kapiotis S, et al. Among authors: exner m. Biochimie. 2006 Jul;88(7):785-91. doi: 10.1016/j.biochi.2006.01.006. Epub 2006 Feb 2. Biochimie. 2006. PMID: 16488068

5

Homocysteine promotes the LDL oxidase activity of ceruloplasmin.

Exner M, Hermann M, Hofbauer R, Hartmann B, Kapiotis S, Gmeiner B. Exner M, et al. FEBS Lett. 2002 Nov 20;531(3):402-6. doi: 10.1016/s0014-5793(02)03571-8. FEBS Lett. 2002. PMID: 12435583 Free article.

6

Salicylate inhibits LDL oxidation initiated by superoxide/nitric oxide radicals.

Hermann M, Kapiotis S, Hofbauer R, Exner M, Seelos C, Held I, Gmeiner B. Hermann M, et al. Among authors: exner m. FEBS Lett. 1999 Feb 19;445(1):212-4. doi: 10.1016/s0014-5793(99)00043-5. FEBS Lett. 1999. PMID: 10069403 Free article.

7

The salicylate metabolite gentisic acid, but not the parent drug, inhibits glucose autoxidation-mediated atherogenic modification of low density lipoprotein.

Exner M, Hermann M, Hofbauer R, Kapiotis S, Speiser W, Held I, Seelos C, Gmeiner BM. Exner M, et al. FEBS Lett. 2000 Mar 17;470(1):47-50. doi: 10.1016/s0014-5793(00)01289-8. FEBS Lett. 2000. PMID: 10722843 Free article.

8

Genistein prevents the glucose autoxidation mediated atherogenic modification of low density lipoprotein.

Exner M, Hermann M, Hofbauer R, Kapiotis S, Quehenberger P, Speiser W, Held I, Gmeiner BM. Exner M, et al. Free Radic Res. 2001 Jan;34(1):101-12. doi: 10.1080/10715760100300101. Free Radic Res. 2001. PMID: 11234992

9

Semicarbazide-sensitive amine oxidase catalyzes endothelial cell-mediated low density lipoprotein oxidation.

Exner M, Hermann M, Hofbauer R, Kapiotis S, Quehenberger P, Speiser W, Held I, Gmeiner BM. Exner M, et al. Cardiovasc Res. 2001 Jun;50(3):583-8. doi: 10.1016/s0008-6363(01)00208-5. Cardiovasc Res. 2001. PMID: 11376634

10

Free and peptide-bound DOPA can inhibit initiation of low density lipoprotein oxidation.

Exner M, Hermann M, Hofbauer R, Kapiotis S, Gmeiner BM. Exner M, et al. Free Radic Res. 2003 Nov;37(11):1147-56. doi: 10.1080/10715760310001595766. Free Radic Res. 2003. PMID: 14703726

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

460 results

Search Page

Filters